References
- Feldman M, Burton M E. Histamine 2-receptor antagonists: standard therapy for acid-peptic diseases. N Engl J Med 1990; 323: 1672–80; 1749–55, 323
- Koelz H R. Treatment of reflux esophagitis with H2 blockers, antacids, and prokinetic drugs: an analysis of randomized clinical trials. Scand J Gastroenterol 1989; 24(Suppl 156)25–36
- Orr W C, Robinson M G, Humphries T J, Antonello J, Cagliola A. Dose-response effect of famotidine on patterns of gastrooesophageal reflux. Aliment Pharmacol Ther 1988; 2: 229–35
- Monnier Ph., Savary M. Contribution of endoscopy to gastrooesophageal reflux disease. Scand J Gastroenterol 1984; 19(Suppl 106)26–45
- Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163–70
- Peto R, Pike M C, Armitage P. Design and analysis of randomized clinical trials requiring prolonged observations of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1–39
- Mausner J, Bahn A. Epidemiology: an introductory text. WB Saunders, Philadelphia 1974; 146–9
- Hetzel D J, Dent J, Reed W D. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95: 903–12
- Masclee A AM, DeBest A CAM, De Graaf R, Cluysenaer O JJ, Jansen J BMJ. Ambulatory 24-hour pH in the diagnosis of gastroesophageal reflux disease. Scand J Gastroenterol 1990; 25: 225–30
- Mattox H E, Richter J E. Prolonged ambulatory esophageal pH monitoring in the evaluation of gastroesophageal reflux disease. Am J Med 1990; 89: 345–56
- Berenson M, Simon T J, Berlin R G. BID regimens of an H2 receptor antagonist heal erosive esophagitis: results of a U.S. double-blind, randomized, multicenter trial [abstract]. Gastroenterology 1990; 98(5, Pt 2)A21
- Festen H PM, Wesdorp I CE, Dekker W. The efficacy of famotidine 20 mg bid vs 40 mg bid in the treatment of erosive/ulcerative reflux esophagitis: significance of severity of esophagitis and duration of therapy [abstract]. Gastroenterology 1991; 100(5, Pt2)A63–#5
- Palmer R H, Frank W O, Rockhold F W, Wetherington J D, Young M D. Cimetidine 800 mg twice daily for healing erosions and ulcers in gastroesophageal reflux disease. J Clin Gastroenterol 1990; 12(Suppl 2)S29–34
- Johnson N J, Boyd E JS, Mills J G, Wood J R. Acute treatment of reflux oesophagitis: a multicentre trial to compare 150 mg ranitidine b.d. with 300 mg ranitidine q.d.s. Aliment Pharmacol Ther 1989; 3: 259–66
- Burget D W, Chiverton S G, Hunt R H. Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and suppression. Gastroenterology 1990; 99: 345–51
- Bell N JV, Hunt R H. Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease. Gut 1992; 33: 118–24